105174-97-8 Usage
Uses
Used in Medicinal Chemistry:
Ethyl 3-bromoisoxazole-5-carboxylate is used as a building block for the synthesis of pharmaceutical drugs due to its unique molecular structure. Its presence in the molecular framework can contribute to the development of new drug candidates with potential therapeutic applications.
Used in Research and Development:
In the field of organic chemistry, Ethyl 3-bromoisoxazole-5-carboxylate is used as a research compound to explore its reactivity and potential applications in the synthesis of complex molecules. Its properties and behavior in various chemical reactions can provide insights into the design of new chemical entities and materials.
Used in Drug Discovery:
Ethyl 3-bromoisoxazole-5-carboxylate is employed as a starting material in drug discovery processes, where its structural features can be exploited to create novel compounds with potential medicinal properties. Its versatility in chemical modifications makes it a valuable asset in the search for new therapeutic agents.
Used in Chemical Synthesis:
Ethyl 3-bromoisoxazole-5-carboxylate is used as a synthetic intermediate in the preparation of various organic compounds. Its presence in the synthesis process can lead to the formation of complex molecules with diverse applications in different industries, including pharmaceuticals, materials science, and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 105174-97-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,1,7 and 4 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 105174-97:
(8*1)+(7*0)+(6*5)+(5*1)+(4*7)+(3*4)+(2*9)+(1*7)=108
108 % 10 = 8
So 105174-97-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H6BrNO3/c1-2-10-6(9)4-3-5(7)8-11-4/h3H,2H2,1H3
105174-97-8Relevant academic research and scientific papers
Process for the preparation of 3,5-disubstituted isoxazoles
-
, (2008/06/13)
A novel process for the preparation of 3-bromo- and 3-chloro-5-substituted isoxazoles is provided. Dibromo- or dichloro-formaldoxime is reacted with an excess of an 1-alkyne derivative of the formula where R is hydrogen, phenyl or 1-6 C alkyl optionally substituted by halogen, OH, OR', CHO, COR', COOR', CONH2, CONR'R" or NHCOR' where, in turn, R' and R", which may be the same or different, are a 1-6 C alkyl or haloalkyl, in the presence of (i) at least an equimolecular amount, with respect to the dibromo- or dichloro-formaldoxime, of an alkaline base selected from the class consisting of sodium and potassium carbonate and bicarbonate and (ii) an inert solvent in which the 1-alkyne is soluble at room temperature.
